These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25907632)

  • 41. Diagnostic considerations in juvenile parkinsonism.
    Paviour DC; Surtees RA; Lees AJ
    Mov Disord; 2004 Feb; 19(2):123-35. PubMed ID: 14978667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkin-associated Parkinson's disease.
    von Coelln R; Dawson VL; Dawson TM
    Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype.
    Klein C; Pramstaller PP; Kis B; Page CC; Kann M; Leung J; Woodward H; Castellan CC; Scherer M; Vieregge P; Breakefield XO; Kramer PL; Ozelius LJ
    Ann Neurol; 2000 Jul; 48(1):65-71. PubMed ID: 10894217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
    Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE
    Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase.
    Byrd RA; Weissman AM
    EMBO J; 2013 Jul; 32(15):2087-9. PubMed ID: 23852447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism.
    Kuroda Y; Mitsui T; Akaike M; Azuma H; Matsumoto T
    J Neurol Neurosurg Psychiatry; 2001 Aug; 71(2):231-4. PubMed ID: 11459900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homozygous exon 4 deletion in parkin gene in a Korean family with autosomal recessive early onset parkinsonism.
    Kim JS; Lee KS; Kim YI; Lee KH; Kim HT
    Yonsei Med J; 2003 Apr; 44(2):336-9. PubMed ID: 12728478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
    Lohmann E; Thobois S; Lesage S; Broussolle E; du Montcel ST; Ribeiro MJ; Remy P; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Brice A;
    Neurology; 2009 Jan; 72(2):110-6. PubMed ID: 18987353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
    Okarmus J; Bogetofte H; Schmidt SI; Ryding M; García-López S; Ryan BJ; Martínez-Serrano A; Hyttel P; Meyer M
    Sci Rep; 2020 Jun; 10(1):10278. PubMed ID: 32581291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Juvenile-onset parkinsonism with digenic parkin and PINK1 mutations treated with subthalamic nucleus stimulation at 45 years after disease onset.
    Nakahara K; Ueda M; Yamada K; Koide T; Yoshimochi G; Funayama M; Kim JH; Yamakawa S; Mori A; Misumi Y; Uyama E; Hattori N; Ando Y
    J Neurol Sci; 2014 Oct; 345(1-2):276-7. PubMed ID: 25106695
    [No Abstract]   [Full Text] [Related]  

  • 52. A homozygous parkin p.G284R mutation in a Chinese family with autosomal recessive juvenile parkinsonism.
    Chen H; Huang X; Yuan L; Xia H; Xu H; Yang Y; Zheng W; Deng H
    Neurosci Lett; 2016 Jun; 624():100-4. PubMed ID: 27177722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.
    Greene JC; Whitworth AJ; Andrews LA; Parker TJ; Pallanck LJ
    Hum Mol Genet; 2005 Mar; 14(6):799-811. PubMed ID: 15689351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
    Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
    Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Definition of a putative pathological region in PARK2 associated with autism spectrum disorder through in silico analysis of its functional structure.
    Conceição IC; Rama MM; Oliveira B; Café C; Almeida J; Mouga S; Duque F; Oliveira G; Vicente AM
    Psychiatr Genet; 2017 Apr; 27(2):54-61. PubMed ID: 27824727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.
    Bilgic B; Bayram A; Arslan AB; Hanagasi H; Dursun B; Gurvit H; Emre M; Lohmann E
    Parkinsonism Relat Disord; 2012 Jun; 18(5):562-6. PubMed ID: 22445249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution, type, and origin of Parkin mutations: review and case studies.
    Hedrich K; Eskelson C; Wilmot B; Marder K; Harris J; Garrels J; Meija-Santana H; Vieregge P; Jacobs H; Bressman SB; Lang AE; Kann M; Abbruzzese G; Martinelli P; Schwinger E; Ozelius LJ; Pramstaller PP; Klein C; Kramer P
    Mov Disord; 2004 Oct; 19(10):1146-57. PubMed ID: 15390068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parkin regulates kainate receptors by interacting with the GluK2 subunit.
    Maraschi A; Ciammola A; Folci A; Sassone F; Ronzitti G; Cappelletti G; Silani V; Sato S; Hattori N; Mazzanti M; Chieregatti E; Mulle C; Passafaro M; Sassone J
    Nat Commun; 2014 Oct; 5():5182. PubMed ID: 25316086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parkin disease: a clinicopathologic entity?
    Doherty KM; Silveira-Moriyama L; Parkkinen L; Healy DG; Farrell M; Mencacci NE; Ahmed Z; Brett FM; Hardy J; Quinn N; Counihan TJ; Lynch T; Fox ZV; Revesz T; Lees AJ; Holton JL
    JAMA Neurol; 2013 May; 70(5):571-9. PubMed ID: 23459986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unaltered alpha-synuclein blood levels in juvenile Parkinsonism with a parkin exon 4 deletion.
    Miller DW; Crawley A; Gwinn-Hardy K; Lopez G; Nussbaum R; Cookson MR; Singleton AB; Hardy J; Dogu O
    Neurosci Lett; 2005 Feb; 374(3):189-91. PubMed ID: 15663960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.